Yamamoto, T., Miyoshi, H., Kakizaki, F., Maekawa, H., Yamaura, T., Morimoto, T., . . . Taketo, M. M. (2020). Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy. Cancers (Basel).
Citação norma ChicagoYamamoto, Takehito, et al. "Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients With Potential Benefit From FGFR Inhibitor Therapy." Cancers (Basel) 2020.
ציטוט MLAYamamoto, Takehito, et al. "Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients With Potential Benefit From FGFR Inhibitor Therapy." Cancers (Basel) 2020.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.